NCT02293564View on ClinicalTrials.gov

Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand

NACompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

January 31, 2015

Conditions
Osteoarthritis
Interventions
DRUG

gevokizumab

Solution for subcutaneous injection

Trial Locations (28)

Unknown

Tucson

Little Rock

Roseville

Sacramento

Santa Monica

Boulder

Denver

Miami

Pinellas Park

Tampa

Vero Beach

West Palm Beach

Indianapolis

Wichita

Hagerstown

Wheaton

Reno

Albuerque

Raleigh

Portland

Duncansville

Austin

Dallas

San Antonio

Waco

Charlottesville

Norfolk

Franklin

All Listed Sponsors
lead

XOMA (US) LLC

INDUSTRY

NCT02293564 - Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand | Biotech Hunter | Biotech Hunter